Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 4/20 | 0.34 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26060438 | 0.98 | PDK2 (0.34) | PDK2HPRT1CA12CA1CA2 | |
| SCHEMBL27048455 | 0.98 | HPRT1 (0.33) | PDK2HPRT1CA12CA1CA2 | |
| SCHEMBL26060440 | 0.97 | PDK2 (0.33) | PDK2CA12CA1CA2CA9 | |
| SCHEMBL20466447 | 0.96 | PDK2 (0.33) | PDK2HPRT1CA12CA1CA2 | |
| SCHEMBL20466438 | 0.96 | PDK2 (0.33) | PDK2HPRT1CA12CA1CA2 | |
| SCHEMBL27048448 | 0.95 | LPL (0.34) | PDK2HPRT1CA12CA1CA2 | |
| SCHEMBL26059984 | 0.95 | PDK2 (0.34) | PDK2HPRT1CA12CA1CA2 | |
| SCHEMBL20466429 | 0.95 | PDK2 (0.32) | PDK2HPRT1CA12CA1CA2 | |
| SCHEMBL20102289 | 0.94 | GPR84 (0.31) | PDK2HPRT1CA12CA1CA2 | |
| SCHEMBL27048456 | 0.94 | CYP1A1 (0.32) | PDK2HPRT1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025840-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2024-01-25 | — | — | US | disclosed |
| US-20240025840-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2024-01-25 | — | — | US | disclosed |
| EP-4235829-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025840-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CYP1A1, TMEM109 | PDK2 2835/4885HPRT1 251/4885CA12 1746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.